A research team from the University of Buffalo School of Pharmacy and Pharmaceutical Sciences have received $10 million to commence four studies, including 1) examine the effects of drug toxicity on cognitive disorders in older adults with HIV; 2) develop urgent therapies to life-threatening infections; 3) explore the disease of obesity; and 4) craft new treatments for chronic obstructive pulmonary disease (COPD). The study lead is Brian Tsuji, professor of pharmacy practice and associate dean for clinical and translational sciences as well as Qing Ma, professor of pharmacy practice and finally Jun Qu, professor of pharmaceutical sciences. Part of this ongoing research effort is funded by a five-year $4 million award from the National Institute of Aging in the National Institutes of Health (NIH) and represents the largest active R01 (competitive grant that supports mature health-related research) at the School of Pharmacy and Pharmaceutic Sciences as well as the second largest R01 at the university.
In fact, Drug toxicity from over prescription represents a growing problem. As Shannon Brownlee and Judith Garber writing for Stat point out the drug i...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).